Showing results (31-40 of 176) with videos related to
Sort By:
Pageof 18
Mycological Research|November 11, 2005
A revision of the descriptions of ectomycorrhizas published since 1961Miriam De Roman, Vanessa Claveria, Ana Maria De MiguelCurrent Oncology Reports|February 26, 2022
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid TumorsAna Luiza Gomes de Morais, Sara Cerdá, Maria de MiguelJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 21, 2013
Simultaneous online SPE-HPLC-MS/MS analysis of docetaxel, temsirolimus and sirolimus in whole blood and human plasmaAlicia Navarrete, M Paz Martínez-Alcázar, Ignacio Durán, et al.Clinical Therapeutics|November 26, 2015
An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy FailedSteven Sherman, Billy Amzal, Emiliano Calvo, et al.Journal of Nephrology|July 2, 2003
Non-heart-beating donors: experience from the Hospital Clinico of MadridAna Isabel Sanchez-Fructuoso, Maria de Miguel Marques, Dolores Prats, et al.Investigational New Drugs|January 16, 2016
Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignanciesEmiliano Calvo, Guru Reddy, Valentina Boni, et al.Breast Cancer Research and Treatment|November 1, 2002
Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II studyJavier Rodríguez, Emiliano Calvo, J Cortes, et al.Journal of Comparative Effectiveness Research|February 4, 2026
Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trialSamuel Vennin, Will Sopwith, Emiliano Calvo, et al.Journal of Clinical Pharmacology|March 16, 2019
Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung CancerEmiliano Calvo, Jong-Seok Lee, Sang-We Kim, et al.Journal for Immunotherapy of Cancer|June 17, 2022
iRECIST and atypical patterns of response to immuno-oncology drugsJorge Luis Ramon-Patino, Sabine Schmid, Sally Lau, et al.Pageof 18